// App-Quantinova.ai

P-400 : Methotrexate versus expectant management for treatment of tubal ectopic pregnancy: an individual participant data meta-analysis (IPD-MA

Researchers

Presenter

  • A Solangon

Principal Investigators

  • M Van Wely

  • N Van Mello

  • B Mol

  • D Jurkovic

Medical Centers

  • University College London Hospital, Gynaecology Diagnostics and Treatment Unit, London, United Kingdom

  • Monash University, Monash Medical Centre, Victoria, Australia

  • University College London, Institute for Women's Health, London, United Kingdom

  • Amsterdam Universtiy Medical Centre, Centre for Reproductive Medicine, Amsterdam, The Netherlands

Locations

  • United Kingdom

  • Australia

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

  • Gastroenterology (GU)

Disease

  • Ectopic pregnancy

  • Mucositis

Biomarkers

  • Beta human chorionic gonadotropin

Drug/Treatment

  • Methotrexate

Outcome

  • N/A


Study Design

  • Randomized

  • Multinational

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A